Sopharma Trading AD Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ventsislav Marinov
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.1yrs |
| CEO ownership | 0.05% |
| Management average tenure | 3.1yrs |
| Board average tenure | no data |
Recent management updates
Recent updates
We're Not Counting On Sopharma Trading AD (BUL:SO5) To Sustain Its Statutory Profitability
Feb 14
If You Had Bought Sopharma Trading AD's (BUL:SO5) Shares Three Years Ago You Would Be Down 27%
Dec 18We Wouldn't Rely On Sopharma Trading AD's (BUL:SO5) Statutory Earnings As A Guide
Aug 10
Sopharma Trading AD's (BUL:SO5) Shareholders Are Down 35% On Their Shares
Jul 20CEO
Ventsislav Marinov
3.1yrs
Tenure
Mr. Ventsislav Stefanov Marinov serves as Chief Executive Officer & Director at Sopharma Trading AD since November 2021. He served as Chief Strategy Execution Officer at Sopharma Trading AD since July 2018...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.1yrs | no data | 0.046% BGN 91.6k | |
| Member of Management Board | no data | no data | no data | |
| Member of Management Board | no data | no data | no data | |
| Chief Innovation Officer & Member of Management Board | no data | no data | no data | |
| Member of Management Board | no data | no data | no data | |
| Director of Technology & Business Solutions and Member of Management Board | no data | no data | no data | |
| Director Supply Chain Management & Operations | 3.9yrs | no data | no data | |
| Chief Human Resources Officer | no data | no data | no data | |
| Chief Executive Officer of Sopharma Trading Serbia | 2.7yrs | no data | no data |
3.1yrs
Average Tenure
Experienced Management: SFT's management team is considered experienced (3.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 07:59 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sopharma Trading AD is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mihail Dimitrov | First Financial Brokerage House |